UNSPSC 51432811: Saralasin acetate

This classification denotes an antihypertensive agent with the molecular formula C42H65N13O10.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FO21Z580M4. The term saralasin acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule saralasin acetate under HS 29371900 and SITC 54154. As of Q4 2014, SARALASIN ACETATE remains US FDA's Preferred Term for this commodity. Saralasin acetate bears US NLM identifiers UMLS ID C0030114 and NCI Concept Code C66528.

SMILES: C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2C[NH]CN2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3CCC(CC3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC.CC(=O)O.O.

UNSPSC 51432811 Saralasin acetate is a Commodity code representing pharmaceutical ingredients and formulations procured by state and local emergency medical services and public health agencies. Based on recent solicitation activity, the code covers emergency life support medications supplied in injectable form — specifically vasopressor, cardiac, and antiarrhythmic agents used in advanced life support protocols. State and local governments soliciting under this code include municipal fire departments and rescue services operating emergency medical transport. The City of Tampa's Purchasing Department has been the primary recent buyer, acquiring these medications for operational use by Tampa Fire Rescue.

The recent activity originates from Florida, where the City of Tampa issued IFB 26P00188 in April 2026 for Advanced Life Support Medications (response due April 8, 2026, with a contract value of $40,000.00). The solicitation required supply of Labetalol, Epinephrine, Adenosine, and Diltiazem in specified unit quantities, with nine-month minimum expiration, ten-day delivery, and full warranty coverage. The bid was designated a Small Local Business Enterprise sheltered market opportunity with a 5 percent discount for SLBE participation. The source contains no additional recent state and local opportunities under this code from other jurisdictions or issuing bodies.